Trending Now
Qualigen Therapeutics Inc (NASDAQ: OLGN) Presents Three Posters at the American...
Qualigen Therapeutics (NASDAQ: OLGN) announced the presentation of three posters at the American Association of Cancer Research, New Orleans.
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Invesco QQQ Trust Series 1 (QQQ) Falters as Goldman Sachs Misses...
Goldman Sachs reported earnings of $8.79 per share, surpassing the estimated $8.10 per share. However, the company's revenue of $12.22 billion fell...
MAKE IT MODERN
LATEST REVIEWS
Atlas Technical Consultants (ATCX) surges post news of all cash deal
Atlas Technical Consultants, Inc. (NASDAQ:ATCX) last traded at $12.13, a gain of over +6.66 (+121.76%). The stock prices surged after Bernhard Capital, a...
MAKE IT MODERN
PERFORMANCE TRAINING
Novavax Inc. (NASDAQ: NVAX) Receive Singapore Health Sciences Authority’s Approval for Nuvaxovid COVID-19 Vaccine
Novavax Inc. (NASDAQ: NVAX) has announced that Singapore Health Sciences Authority has issued preliminary clearance for the Nuvaxovid COVID-19 vaccine for active immunization against...
Nektar Therapeutics (NASDAQ:NKTR) Reports Q3 2020 Financial Results And Bempegaldesleukin Development Updates
Nektar Therapeutics (NASDAQ:NKTR) has announced its Q3 2020 financial results for the period ended September 30, 2020. At the end of the quarter, the...
Sugarmade Inc (OTCMKTS:SGMD) Positions as Vertically Integrated Farm-to-Door Cali Cannabis Leader (GNLN, CRLBF, SNDL)
The legal cannabis trend is a long-term phenomenon driven by expanding demand as the inevitable broad legalization of recreational pot marches forward.
Investigational New Drug (IND) from Jaguar Health Inc. (NASDAQ:JAGX) for Crofelemer (Mytesi®) for Prophylaxis...
The U.S. Food and Drug Administration (FDA) activated the investigational new drug (IND) application filed by Napo Pharmaceuticals, Inc., a wholly-owned subsidiary of Jaguar...
Kintara Therapeutics Inc (NASDAQ: KTRA) Posts Topline Read Out Of Phase 2 Clinical Trial...
Kintara Therapeutics Inc (NASDAQ: KTRA) posted topline information from its phase 2, open-label clinical trial of VAL-083, its lead compound.
The company is conducting a...
MAKE IT MODERN
